These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Agranulocytosis induced by vancomycin in an ESRD patient on CAPD. Jo YI, Yoon JH, Shin SY, Chang WC, Kim BK, Jin CJ, Song JO. Korean J Intern Med; 2004 Mar; 19(1):58-61. PubMed ID: 15053046 [Abstract] [Full Text] [Related]
3. Toxic epidermal necrolyis after vancomycin use: a case report and discussion of management. Changela A, Javaiya H, Rickenback K, Elnawawi A, Changela K. Am J Ther; 2013 Mar; 20(2):223-5. PubMed ID: 21273948 [Abstract] [Full Text] [Related]
5. Successful Use of High-dose Daptomycin in a Child With Staphylococcus aureus Endocarditis. Prabhudesai S, Kanjani A, Nambi PS, Gnanasambandam S, Ramachandran B. Pediatr Infect Dis J; 2016 May; 35(5):517-8. PubMed ID: 27074655 [Abstract] [Full Text] [Related]
6. Neutropenia associated with vancomycin therapy. Kauffman CA, Severance PJ, Silva J, Huard TK. South Med J; 1982 Sep; 75(9):1131-3. PubMed ID: 7123341 [No Abstract] [Full Text] [Related]
7. Outcomes and costs associated with a history of vancomycin exposure in patients with MRSA-related complicated bacteremia and infective endocarditis. Brown J, Brown KA, Forrest A. Clin Ther; 2011 Oct; 33(10):1475-82. PubMed ID: 21925733 [Abstract] [Full Text] [Related]
17. A comparison of telavancin and vancomycin for treatment of methicillin-resistant Staphylococcus aureus infections: A meta-analysis. Liu Y, Wang J. Int J Clin Pharmacol Ther; 2017 Nov; 55(11):839-845. PubMed ID: 28793957 [Abstract] [Full Text] [Related]